Surgical Treatment of Non-embolized Patients with Nasoangiofibroma  by Fonseca, Adriano Santana et al.
583
Brazilian Journal of otorhinolaryngology 74 (4) July/august 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Surgical Treatment of Non-
embolized Patients with 
Nasoangiofibroma
   Summary
Adriano Santana Fonseca1, Eriko Vinhaes2, Viviane 
Boaventura3, Nilvano Alves de Andrade4, Lislane 
Andrade Dias5, Vyrna Medeiros6, Fernando 
Coifman7 
1 Specialist in ENT and head and neck surgery by the HC/ UNICAMP. Specialist in Forensic Medicine at SSP/BA, Adjunct Professor of head and neck surgery at Santa 
Casa de Misericórdia da Bahia - Hospital Santa Izabel. Specialist in swallowing disorders and head and neck surgery at the Núcleo de Otorrinolaringologia e Estudos da 
Voz/Hospital da Bahia /Hospital Português.
2 Specialist in ENT, otorhinolaryngologist, Adjunct Professor of rhinology at the ENT Department of the Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
3 MSc in pathology at FIOCRUZ/ UFBA, PhD student at FIOCRUZ UFBA, Adjunct Professor of ENT at Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
4 PhD in ENT at USP, Head of the ENT and Head and Neck Department at Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
5 MD, Resident at the ENT and Head and Neck Surgery Department at Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
6 MD, Resident at the ENT and Head and Neck Surgery Department at Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
7 MD, Resident at the ENT and Head and Neck Surgery Department at Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
Santa Casa de Misericórdia da Bahia, Hospital Santa Izabel.
Send correspondence to: Adriano Santana Fonseca - Unidade de Otorrinolaringologia e Cirurgia Cérvico-Facial do Hospital Santa Izabel. Praça Almeida Couto 500 
Nazaré Salvador BA 40050-410.
This paper was submitted to the RBORL-SGP (Publishing Manager System) on 5 April 2007. Code 4411.
The article was accepted on 12 September 2007.
Juvenile nasopharyngeal angiofibroma (JNA) is an 
uncommon tumor of the sphenopalatine foramen. Surgery 
combined with preoperative embolization has been the 
treatment of choice for JNA patients without intracranial 
invasion. This study aims to assess the viability of surgically 
treating non-embolized patients with JNA (types I-III according 
to Fisch). Materials And Method: This is a retrospective, 
descriptive study based on the medical records of 15 patients 
with histologically confirmed JNA (Fisch’s types I- III), who 
underwent surgical treatment without pre-op embolization 
in our institution between 2000 and 2005. Results: Seven of 
the fifteen patients were approached endoscopically, four 
through the transantral approach, three were treated with the 
combined transmaxillary and endoscopic approach, and one 
with the combined transmaxillary and transpalatal approach. 
Six patients required intraoperatory blood transfusion, 
averaging volumes of 1.3 unit/patient. There were no cases 
of death or significant morbidity. Eleven of the fifteen patients 
were followed for an average of twelve months and 27% of 
them relapsed. Four patients did not comply with the follow-
up scheme. Conclusion: Resection of JNF types I-III was 
safely completed in non-embolized patients. The observed 
levels of intraoperative bleeding, occurrence of complications, 
and rates of recurrence were close to those seen in embolized 
patients as found in the literature.
Keywords: treatment, embolization, juvenile nasopharyngeal 
angiofibroma, skull base.
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INTRODUCTION
Juvenile nasopharyngeal angiofibroma (JNA) is an 
uncommon tumor that develops almost exclusively in 
young men. It accounts for 0.05% of all head and neck 
tumors1,2. Although it is considered a benign neoplasm, this 
tumor is not encapsulated, may lead to local destruction 
and has high relapse rates1. This vascular tumor emerges 
mainly from the sphenopalatine foramen and may extend 
all the way to the middle cranial fossa3,4.
According to the scheme proposed by Fisch5, these 
tumors  may be contained within the nasal cavity and 
nasopharynx (I), invade the face sinuses or the pterygopa-
latine fossa (II), expand towards the infratemporal fossa, 
orbit, and parasellar region (III) or present intracranial 
invasion (IV).
Surgery is considered to be the best treatment 
option for JNA6 and many are the isolated and combined 
procedures and approaches to resect the tumor, such as 
the endoscopic, transmaxillary and transpalatine7. Intra-
operative bleeding may occur in any of the approaches 
and has been one of the main perioperative complications. 
Preoperative arterial embolization has been used syste-
matically to reduce the amount of bleeding and the use 
of blood byproducts during surgery with good results4,7. 
However, there is no consensus as to the routine use of 
preoperative embolization, given its high cost and incon-
sistent availability of the procedure in care centers.
This paper aims to assess the possibilities of sur-
gically treating patients for JNA without preoperative 
embolization looking at surgery time, volume of red cell 
packs, intra and postoperative complications, and tumor 
relapse rates.
MATERIALS AND METHOD
This descriptive, retrospective study used data from 
the medical records of fifteen patients who underwent 
JNA resection surgery without preoperative tumor embo-
lization between 2000 and 2005. All patients underwent 
nasofibroscopy with a flexible 3.2mm Machida scope and 
had sinus CT images taken.
Diagnostic criteria comprehended history of epis-
taxis and/or nasal obstruction, presence of angiomatous 
tumor under endoscopy, and CT image showing expansive 
formations in the nasal cavity with or without invasion into 
the sinuses, rhinopharynx, pterygomaxillary fossa, infra-
temporal fossa, orbit, and intracranial area, after contrast 
uptake. Tumors were rated based on the criteria developed 
by Fisch. Clinical diagnosis was confirmed postoperatively 
through histology exams done on the surgical specimens. 
All patients were operated on by the same surgeon.
None of the patients received adjuvant treatment 
such as hormone therapy, chemotherapy, or radiotherapy 
perioperatively.
Patients with previous history of JNA surgery were 
excluded. This study was approved by the Hospital Ethics 
and Research Committee under permit FR - 67401 and 
CAAE (CAAE - 0022.0.057.000-05).
Fentanyl (3Mcg/Kg), propofol (2.5mg/Kg), cisa-
tracurium (0.15mg/Kg) were used in general anesthesia 
and dexamethasone (10mg) in anesthetic induction; and 
sevoflurane (2%) with remifentanil (0.2 to 0.5mg/Kg/min) 
in sustaining anesthesia. Blood pressure was kept at an 
average 60mmHg intraoperatively, and tranexamic acid 
(10mg/Kg) was administered as a prophylactic measure 
against bleeding. Volemic replacement was done with 
crystalloids and blood transfusion was indicated whenever 
hemoglobin was under 7g/dl.
When approaching patients endonasally, the surge-
on used 0, 30 and 45 degree endoscopes (Comeg, Storz), 
nasal vasoconstriction with cotton swabs drenched in 
lidocaine and adrenalin solution (1:3000), and irrigation 
with saline solution at 0.9% and 4ºC. Patients were then 
submitted to a partial medial turbinectomy to expose the 
sphenoethmoidal recess and the sphenopalatine foramen 
region, defining the superior border of the tumor in the 
cases where it involved the tail or body of the concha. 
Sphenoidal sinusotomy was done via the sphenoethmoi-
dal recess and ethmoidectomy with inferior and posterior 
traction of the tumor when the neoplasm involved the 
posterior-superior portion of the nasal fossa. Maxillary 
antrostomy, with detachment of the posterior fontanel 
to expose the sphenopalatine foramen, was indicated to 
determine the lateral borders of the tumor, in the pterygo-
palatine fossa or the infratemporal fossa. The tumor’s 
arterial pedicles (mainly the often numerous terminal 
branches of the internal maxillary artery) that surround it 
inferiorly and superiorly were dissected and ligated with 
a monopolar electrocautery. A bipolar cautery was used 
in the vessels close to the meninges and the optic nerve, 
whereas neurosurgery 200 clips were placed in the larger 
diameter vessels.
In type-I patients, after vascular ligation, the tumor 
was pulled towards the rhinopharynx until it was complete-
ly detached. In type II and III patients, part of the palatine 
bone vertical lamina and of the maxillary sinus posterior 
wall were removed endoscopically, thus exposing the 
pterygopalatine fossa and part of the infratemporal fossa. 
The transeptal approach as described by Wormald8 was 
preferred in patients operated on more recently. Vascular 
ligation was conducted after the lateral borders of the 
tumor were identified as described above. The tumor was 
then detached up to its posterior borders, in the inferior 
orbital fissure and the venous pterygoid plexus.
When the lateral border could not be reached en-
doscopically, the transmaxillary approach was used in a 
medial labial rhinotomy or in a facial medial degloving 
procedure, as described by Denker and Caldwell-Luc 
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respectively. The transpalatine approach with microsco-
pe assisted dissection combined with the transmaxillary 
approach was used in one case where a bulky tumor was 
adhered posteriorly.
Isolated transmaxillary approach was used in tumors 
invading the entire nasal fossa, regardless of type, that ren-
dered impossible the use of the endoscopic approach.
All patients stayed in intensive care units for 24-48 
hours after surgery.
Nasal packing, when required, was removed after 
48-72 hours. Nasal irrigation with hypertonic saline solution 
was indicated after hospital discharge and follow-up was 
conducted for nasofibroscopy exams at the institution’s 
outpatient ward. Endoscopic CT face scans were taken 
whenever relapsing tumors were suspected.
RESULTS
All fifteen patients operated for JNA resection wi-
thout embolization were staged based on the model pro-
posed by Fisch. Eight patients (53%) had type II disease, 
followed by four (27%) with type III, and three (20%) with 
type I tumors. None of the patients had type IV disease. 
The endonasal and transmaxillary approaches were elected 
for patients with disease types I and II. Combined transma-
xillary and endonasal or transmaxillary and transpalatine 
approaches were reserved for type III tumors.
Age averaged between 17 and 19 years within the 
three groups of patients. Surgery took slightly longer for 
type II tumors, but no statistically significant difference 
was found between the three groups. Average surgery 
length was 140 minutes. Six of the fifteen patients had 
intraoperative bleeding requiring blood transfusion. They 
averaged 1.3 units of red cell pack per patient.
Three patients had postoperative bleeding, two from 
group II and one from group III. Bleeding episodes were 
controlled by ligating the maxillary artery. All patients were 
discharged without requiring nasal packing. There were 
no postoperative complications.
All fifteen patients who underwent surgery were 
followed up for 12-63 months.
Three of the patients (27%) had relapsing tumors 
and were referred to tumor resection. None had relapsing 
tumors after the second procedure.
The data above is described on the chart below.
DISCUSSION
Some authors believe embolization is indispen-
sable when resecting nasopharyngeal angiofibromas 
endoscopically8,9. Most papers in the literature comparing 
surgical treatment with and without embolization have 
demonstrated reduced intraoperative blood loss and fewer 
blood transfusions when embolization is done10,12. Blood 
loss is reduced by 836 to 1200 ml per non-embolized pa-
tient; and by 400 to 600 ml per embolized patient10-26.
Chart
Stage 
(Fisch)
Patient # Age (years) Approach
Intraop Blood 
Transfusion
Surgery 
Duration
Postop Bleeding Relapse
Follow-
up (mon-
ths)
I
1 24 Endonasal Not 02:40 Not Not 46
2 15 Transmaxillary 1 unit 02:10 Not Not 45
3 19 Endonasal Not 02:20 Not Not 42
II
4 15 Endonasal Not 02:20 Not Not 12
5 24 Endonasal 6 units 02:50 Not Not 48
6 19 Endonasal 3 units 03:20 Yes Yes 63
7 19 Transmaxillary 2 units 03:25 Yes Not 58
8 12 Transmaxillary Not 02:00 Not Not 47
9 16 Transmaxillary Not 02:45 Not Not 23
10 24 Endonasal 5 units 03:20 Not Not 24
11 24 Endonasal Not 02:40 Not Not 12
III
12 16
Endonasal + 
Transmaxillary
3 units 02:05 Not Yes 22
13 24
Transmaxillary + 
Transpalatine
Not 03:10 Yes Yes 29
14 23
Endonasal + 
Transmaxillary
Not 02:45 Not Not 25
15 08
Endonasal + 
transmaxilar
Not 01:30 Not Not 36
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In terms of blood transfusion, the values ranged 
between 3 and 4.4 units of red cell pack per patient in the 
non-embolized group, when compared to 0 to 2 units in 
the group of embolized patients11-26.
This study comprehended patients with disease 
types I to III according to Fisch. Intraoperative blood 
transfusion volumes were comparable to those found by 
other authors looking at preoperative embolization - 0 to 
2 units per patient11-26 against 1.3 units per patient in this 
study. Bleeding was reduced as a result of the adopted 
surgical tactic, which included systematic tumor vascular 
ligation in the beginning of the procedure, approaching 
not only the maxillary artery branch, but also all other 
arterial branches irrigating the neoplasm. By maintaining 
the patients’ blood pressure at a lower level (60mmHg) 
until the tumor has been removed and tranexamic acid 
applied, it is believed that intraoperative bleeding was 
significantly reduced.
Moulin et al. do not indicate embolization as a 
routine preoperative procedure. Considering the blood 
losses of embolized and non-embolized patients, the 
authors concluded that the procedure should only be 
offered to patients with larger tumors12. Petruson et al., 
looking at intraoperative bleeding, did not encounter sta-
tistically significant differences between embolized and 
non-embolized patients13. The authors found higher JNA 
relapse rates among embolized patients. Mc Combe et al. 
suggested that preoperative embolization may compromise 
the identification of surgical margins as it reduces tumor 
size, consequently increasing chances of relapse14.
Many papers also point out the benefits of preope-
rative arterial embolization in controlling intraoperative 
bleeding8,9,15,17, reducing it by as much as fifty percent15, 
thus allowing the full excision of the tumor16, lower relap-
se rates and neurological complications9,17, and reduced 
surgery duration when associated with the endoscopic 
approach alone18. Nevertheless, the most important prog-
nostic factor for relapse is early staging and knowing the 
extension of the tumor19.
Maxillary artery embolization is a relatively safe 
invasive procedure. Complication rates may be as high 
as 27%20, most of which are temporary21 in spite of the 
few (2%) severe ones22. Such complications may include 
occlusion of the central retinal artery and consequent tem-
porary blindness23, oronasal fistula due to tissue necrosis24, 
occlusion of the middle cerebral artery followed by stroke, 
and occlusion of the ophthalmic artery25.
Preoperative embolization may cost between USD 
2,000 and USD 11,00020,21,27, being therefore a procedure 
that most public and non-profit hospitals in Brazil cannot 
afford. We could not find indexed papers discussing the 
costs of this procedure in Brazil.
CONCLUSION
This study presents a review of fifteen JNA patients 
who underwent surgery without preoperative embolization 
within a five-year span. Intraoperative and postoperative 
complication rates and blood loss levels were similar to 
those found in the literature for patients submitted to pre-
operative embolization, thus indicating that the procedure 
without preoperative embolization can be safely offered to 
selected patients. Additional comparative studies must be 
conducted so that a treatment routine can be developed 
for these patients.
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